Comparative safety and immunogenicity trial of two killed Leishmania major vaccines with or without BCG in human volunteers

Clin Dermatol. 1996 Sep-Oct;14(5):489-95. doi: 10.1016/0738-081x(96)00071-5.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic* / administration & dosage
  • Adjuvants, Immunologic* / adverse effects
  • Adolescent
  • Adult
  • Animals
  • Antibodies, Protozoan / biosynthesis
  • Antigens, Protozoan / immunology
  • BCG Vaccine / administration & dosage
  • BCG Vaccine / adverse effects
  • BCG Vaccine / immunology*
  • Double-Blind Method
  • Female
  • Humans
  • Interferon-gamma / biosynthesis
  • Leishmania major / immunology*
  • Male
  • Middle Aged
  • Pain / etiology
  • Placebos
  • Protozoan Vaccines / administration & dosage
  • Protozoan Vaccines / adverse effects
  • Protozoan Vaccines / immunology*
  • Pruritus / etiology
  • Safety
  • Skin Tests
  • Tuberculin Test
  • Vaccination
  • Vaccines, Inactivated / administration & dosage
  • Vaccines, Inactivated / adverse effects
  • Vaccines, Inactivated / immunology*

Substances

  • Adjuvants, Immunologic
  • Antibodies, Protozoan
  • Antigens, Protozoan
  • BCG Vaccine
  • Placebos
  • Protozoan Vaccines
  • Vaccines, Inactivated
  • leishmanin
  • Interferon-gamma